Ganti, Apar Kishor https://orcid.org/0000-0003-3724-2671
Fillmore, Nathanael R.
Bihn, John
La, Jennifer
Brophy, Mary T.
Do, Nhan V.
Kelley, Michael
Article History
Received: 5 August 2022
Accepted: 7 February 2023
First Online: 1 March 2023
Declarations
:
: AKG: Consultant: Genentech, AstraZeneca, G1 Therapeutics, Jazz Pharmaceuticals, Flagship Biosciences Research Support: Takeda, DSMC: Y-mAbs Therapeutics. MK: Executive Program Director of Oncology, Specialty Care Services, VHA, Department of Veterans’ Affairs. The other authors do not have any conflicts of interest.
Free to read: This content has been made available to all.